Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupuncture for Cardiac Autonomic Neuropathy in Type 2 Diabetes
NCT07907536Recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- May 2025
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Randomised trial in diabetic cardiovascular autonomic neuropathy (CAN) (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Total Clinical Effective Rate Based on TCM Syndrome Score at 6 weeks. Started May 2025; status: recruiting.
02
Conditions
diabetic cardiovascular autonomic neuropathy (CAN)
Beyond the preview
Go deeper on NCT07907536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07907536.